US drug pricing shake-up threatens access to medicines in Europe – POLITICO

For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on pharmaceuticals — will play out.

“It’s too early to understand what is in scope, or the wider implication on Europe or member…